Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey
by
Kawamura, Kazuo
, Imanishi, Noriaki
, Izumi, Kazuo
, Adachi, Takeya
, Umehara, Senkei
, Suematsu, Makoto
, Furusawa, Yoshihiko
, Nishizaki, Yuji
in
Databases as Topic - organization & administration
/ Genetic Testing - methods
/ Genetic Testing - standards
/ Humans
/ Information Dissemination
/ International Cooperation
/ Japan
/ Medical research
/ Policy
/ Primary care
/ R&D
/ Rare diseases
/ Rare Diseases - classification
/ Rare Diseases - diagnosis
/ Rare Diseases - genetics
/ Research & development
2017
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey
by
Kawamura, Kazuo
, Imanishi, Noriaki
, Izumi, Kazuo
, Adachi, Takeya
, Umehara, Senkei
, Suematsu, Makoto
, Furusawa, Yoshihiko
, Nishizaki, Yuji
in
Databases as Topic - organization & administration
/ Genetic Testing - methods
/ Genetic Testing - standards
/ Humans
/ Information Dissemination
/ International Cooperation
/ Japan
/ Medical research
/ Policy
/ Primary care
/ R&D
/ Rare diseases
/ Rare Diseases - classification
/ Rare Diseases - diagnosis
/ Rare Diseases - genetics
/ Research & development
2017
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey
by
Kawamura, Kazuo
, Imanishi, Noriaki
, Izumi, Kazuo
, Adachi, Takeya
, Umehara, Senkei
, Suematsu, Makoto
, Furusawa, Yoshihiko
, Nishizaki, Yuji
in
Databases as Topic - organization & administration
/ Genetic Testing - methods
/ Genetic Testing - standards
/ Humans
/ Information Dissemination
/ International Cooperation
/ Japan
/ Medical research
/ Policy
/ Primary care
/ R&D
/ Rare diseases
/ Rare Diseases - classification
/ Rare Diseases - diagnosis
/ Rare Diseases - genetics
/ Research & development
2017
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey
Journal Article
Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey
2017
Request Book From Autostore
and Choose the Collection Method
Overview
Japan has been facing challenges relating to specifically defined rare diseases, called Nan-Byo in Japanese (literally 'difficult'+'illness'), and has already taken measures for them since 1972. This governmental support has surely benefited Nan-Byo patients; however, those suffering from medically unidentified conditions do not fall into this scheme and thus still confront difficulty in obtaining an examination, a diagnosis, and a treatment. To identify such rare and often undiagnosed diseases, we must integrate systematic diagnosis by medical experts with phenotypic and genetic data matching. Thus, in collaboration with Nan-Byo researchers and the Japanese universal healthcare system, the Japan Agency for Medical Research and Development launched the Initiative on Rare and Undiagnosed Diseases (IRUD) in 2015. IRUD is an ambitious challenge to construct a comprehensive medical network and an internationally compatible data-sharing framework. Synergizing with existing next-generation sequencing capabilities and other infrastructure, the nationwide medical research consortium has successfully grown to accept more than 2000 undiagnosed registrants by December 2016. We also aim at expanding the concept of microattribution throughout the initiative; that is, proper credit as collaborators shall be given to local primary care physicians, nurses and paramedics, patients, their family members, and those supporting the affected individuals whenever appropriate. As it shares many challenges among similar global efforts, IRUD's future successes and lessons learned will significantly contribute to ongoing international endeavors, involving players in basic research, applied research, and societal implementation.
Publisher
Nature Publishing Group
This website uses cookies to ensure you get the best experience on our website.